Week 3 Flashcards

1
Q

Glial Cells

A

• Glia support neurons
• Often quoted as outnumbering neurons but
probably about the same
• Glia = ‘glue’ – but don’t hold neurons together
• Numerous types and many function
• Divisions – microglia and macroglia
• Microglia – brain’s immune system
• Macroglia
• Myelination (Schwann cells in PNS, oligodendrocytes in
CNS
• Structural/functional support of neurons (astrocytes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Glial Cells - Myelination

A
Shwann cells in the PNS
Oligodendrocytes in CNS
• Axon myelination in the PNS
• Multiple cells along a single axon
• Cell turns around the axon several times wrapping it in membrane
• Can guide axon regeneration after damage
• Nerves can regrow
• Axon myelination in the CNS
• Single cells provides several
segments, often multiple axons
• Cell extensions wrap around the axon
• No axon regeneration after damage
• No regrowth in the CNS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Glial cells - Astrocytes

A
• Star shaped – ‘astro’
• Surround neurons and contact
brain’s vasculature
• ‘Blood-brain barrier’ (seal off
capillaries)
• Support – nutrition, growth
factors, clear waste, physical
matrix to separate neurons
• Activity - modulate neural activity,
maintain efficient signalling (K+
and neurotransmitter uptake),
maintain axon function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Glial cells - Microglia

A

Brain’s immune system
• Response to injury or disease – multiply, release antigens,
phagocytosis
• Rapidly activate to stop pathogens
• Anti-inflammatory response, eg after stroke
• Eliminate excess neurotransmitters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Glial Cell Dysfunction - MS

A
• Acute, inflammatory
autoimmune disease
• Brain, spinal cord, optic nerves
• 36.6 / 100,000
• Female : male 2.3 : 1
• Increased prevalence with
increasing south latitude in
Australia (7 times more in
Hobart than Queensland)
• No cure but treatments to
manage symptoms and slow
progression – immune
supress, anti-inflammatories
Visual - blurred and double
vision, nystagmus, ‘flashes’
• Motor - weakness of muscles, slurred speech, muscle wastage, poor posture, tics
• Sensory - numbness, tingling,
pain
• Coordination and balance
• Cognitive - short- and longterm memory, forgetfulness,
slowed recall
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Glial Cell Dysfunction - Tumours

A
• Gliomas are most common
(40-50% of all brain tumours)
• Relatively fast growing, arising
from any type of glial cells,
hence gliomas, astrocytomas,
and oligodendrogliomas. 
eg. Frontal lobe astrocytoma, Temporal lobe glioblastoma multiforme
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What makes up a typical neuron?

A

axon terminals, axon, cell body (soma) and dendrites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are Ribosomes (the

speckles) and endoplasmic reticulum, and what do they do?

A

generate proteins:

neurotransmitters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the golgi complex?

A

package neurotransmitter

into vesicles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are microtubules?

A

transport vesicles
and proteins
along the axon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are synaptic vesicles?

A

contain
neurotransmitter
for release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is mitochondria?

A

energy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Neuron – Signalling Specialisations

A

• Specialised secretory cell
• Targeted and long distance
• Irritability – responds to being stimulated
Axon terminals + axons transmit information
cell body (soma) integrates information
dendrites collect information

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Dendrites

A

• Collect information from other
connected neurons (synapse)
• Chemical messengers
(neurotransmitters) bind to receptors
and cause electrical changes
• Electrical changes spread from the dendrite and into the soma
• Electrical changes weaken with distance and over time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Cell body (soma)

A

• Integrates information from all of the inputs (synapses)
• Electrical changes from all inputs spread to the soma and add together
• Critical point – the junction
between the soma and the axon (axon hillock)
• If electrical changes beyond the axon hillock reaches a critical value, then the neuron will fire

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Axon

A
• Transmits the signal away
from the soma
• Signal is transmitted
electrically by action
potential
• Myelin protects the axon and
promotes fast transmission
of the signal
• Action potentials occur at
Nodes of Ranvier
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Axon terminals

A
• Transmits the signal to
other neurons
• Signal is transmitted
chemically by neurotransmitters
• Terminal buttons store
neurotransmitter in vesicles
• Action potential triggers
release into the synapse
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Sensory Neuron

A

Unipolar (pseudo-unipolar)
• Afferent neuron – into the CNS
• Messages from receptors to the
brain or spinal cord

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Motor Neuron

A

Multipolar
• Efferent neuron – out of the CNS
• Messages from the brain or spinal
cord to the muscles /organs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Interneuron

A
Multipolar
• Relays message from
sensory neuron to motor
neuron in the spinal cord
• Local connections in the
brain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Neuron Dysfunction - Dementia

A

Dementia is caused by neurodegeneration – the damage and death
of the brain’s neurons
Australian statistics
• Second leading cause of death (leading in females)
• In 2018, estimated 425,416 Australians living with dementia
• Age most important risk factor – 3 in 10 people over the age of
85 and almost 1 in 10 people over 65 have dementia
• Other risk factors – CV health, diabetes, cholesterol, family
history, head injury
• Main types – Alzheimer’s disease (AD), frontotemporal dementia (FTD), vascular dementia (VD), dementia with Lewy bodies (DLB)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Alzheimer’s Disease

A
• Cerebral atrophy
• External surface of the brain
with widened sulci and narrowed gyri
• Commences in medial temporal lobe – hippocampus and entorhinal cortex
• Early memory loss and spatial
navigation impairment
• Later progresses to broader
cortex and subcortical
• Motor difficulties, impairments in executive planning and decision making 
cortical loss and thinning of gyri, shrunken hippo campus, enlarged ventricles
Plaques and Tangles
• Abnormal protein aggregates
associated – amyloid beta and tau
• Aβ – extracellular plaques
• Synapse toxicity ???
• Tau – intracellular tangles; twisted ropes within swollen cell body
• Axon toxicity ???
• Maybe causative, maybe not
• Latest – Herpes virus ???
• Genetic component
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Membrane Potentials

A
Resting Potential -70mV
when there are more positive ions in a certain part of the inside of the cell compared to the outside: 
• Local change
• Less polarisation (closer to zero)
• “DEPOLARISED”
• Spreads (decremental)
• Decays (time)
when there are less positive ions in a certain part of the inside of the cellcomapred to the outside: 
Local change
• More polarisation (away from zero)
• “HYPERPOLARISED”
• Spreads (decremental)
• Decays (time)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Collection and Integration - graph

A
Local polarisation
change at the
dendrites (and soma)
• Depolarisation –
excitatory postsynaptic potential; the line rises on a graph
• Hyperpolarisation –
inhibitory post-synaptic
potential; the line dips on a graph
25
Q

Collection and Integration - in a cell

A
Neurotransmitter binds and
an associated ion channel
opens or closes, causing a
Post-Synaptic Potential (PSP)
• EPSP – inside gets more
positive (usually Na+ flows in)
• IPSP – inside gets more
negative (either K+
flows out or Clflows in)
• Fast acting
• Effect of many local EPSPs and IPSPs
spread (decremental) and decay
• Axon hillock – portion of the soma
adjacent to the axon
• If membrane potential just beyond the
hillock reaches a threshold (-55mV)
• Triggers ACTION POTENTIAL
26
Q

Transmission Along the Axon

Action Potential

A
Dendrites and soma –
decremental conduction
• Axon – Action Potential (AP)
– active ‘firing’ of the neuron
• Local depol / repol
• Active so FAST
• Triggered by depolarization
• Key – Voltage Gated Ion
Channels
27
Q

Transmission Along the Axon

Voltage Gated Ion Channels

A
Open and close depending
on the local membrane
potential
• Voltage gated sodium
channels – allow Na+
to rush in - Depolarisation
• Voltage gated potassium
channels – allow K+
to rush out – Repolarization
28
Q

Three Phases of the AP

A

Rising phase- 1ms, sodium channels open then potassium channels open. At +50mV sodium channel closes.
Repolarisation - 1.5ms when sodium channel closes until 2ms when potassium channels closes.
Hyperpolarisation- 2-4.5ms
Absolute refractory- 1-3ms period
Relative refractory- 3-4.5ms

29
Q

Transmission Along the Axon

A
  • AP is non-decremental – it does NOT decay or diminish
  • Travels down the axon rather than passive spreading
  • Regenerate so travel for long distances without signal loss
30
Q

Saltatory Conduction

A

Passive conduction (fast and decremental) along each myelin segment to next node of Ranvier
• New action potential generated at each node
• Fast conduction along myelin segments results
in faster conduction than in unmyelinated axons
• Conduction in Myelinated Axons: Saltatory Conduction

31
Q

The Synapse is made up of/

A
Presynaptic terminal
• Vesicles containing NT
• Incoming AP triggers voltage
gated calcium channels
• Ca2+ influx triggers NT release
• Receptors for NT re-uptake
Junction / cleft / gap
• NT ‘float’ briefly after release
Post-synaptic terminal
• Receptors for the NTs
32
Q

Presynaptic terminal

A
Vesicles containing NT
• Incoming AP triggers voltage
gated calcium channels
• Ca2+ influx triggers NT release
• Receptors for NT re-uptake
33
Q

Junction / cleft / gap

A

NT ‘float’ briefly after release

34
Q

Post-synaptic terminal

A

Receptors for the NTs

35
Q

Types of synapses

A

Most common types of synapses
• Axodendritic (axon terminal buttons on dendrites)
• Axosomatic (axon terminal buttons on soma / cell body)
But also
• Dendritic spines (axon terminal buttons on spines of dendrites)
• Dendrodendritic – dendrite to dendrite, and often bidirectional transmission
• Axo-axonic – (can mediate presynaptic facilitation and inhibition of that button on the post-synaptic neuron)

36
Q

Presynaptic

A

Axon terminals

37
Q

Postsynaptic

A

At postsynaptic terminals on dendrite

38
Q

The Synapse - Other Types

A
‘String of beads’
• Non-directed
• Diffuse release from
varicosities
• Neurohormones and
modulatory
neurotransmitters
Gap Junction
• Electrical synapse
39
Q

Neurotransmitters

A
2 basic types of
neurotransmitter
molecules (and 2 types
of vesicles)
• Small
• Large
One neuron can
produce and release
two (or more)
neurotransmitters
>100 identified
40
Q

Neurotransmitters - examples of small molecules

A

Glutamate, GABA, Acetylcholine, Norepinephrine

41
Q

Neurotransmitters - examples of large molecules

A

Also endorphins,
enkephalins, some
hormones
Substance P

42
Q

Neurotransmitters - small molecules

A
Synthesized in
cytoplasm of the
terminal button
• Packaged in vesicles by
the Golgi complex
• Vesicles stored in
clusters next to presynaptic membrane,
waiting for the trigger to
be released.
43
Q

Neurotransmitters - large molecules

A

Neuropeptides – short proteins (3-36
amino acids)
• Assembled in the cell body by ER/ribosome
• Packaged by Golgi complex
• Transported to the axon terminal via
microtubules
• Example – endorphins - “Endogenous opioids”
• Produce analgesia
• Receptors were identified before the natural ligand was

44
Q

Small Molecules - Classes

A
Amino acids
• Building blocks of proteins
• Fast-acting synapses in the CNS
• Glutamate –excitatory
• GABA – inhibitory
• Aspartate and glycine
Monoamines
• Synthesized from amino acid
• Diffuse effects (branched, string of beads synapses)
• Catecholamines (synthesized
from tyrosine): dopamine,
norepinephrine, epinephrine
• Indolamines (synthesized from
tryptophan): serotonin
Acetylcholine (ACh)
• Acetyl group + choline
• Neuromuscular junction
• Autonomic NS
Soluble gases
• Nitric oxide, carbon monoxide
• Retrograde transmission –
feedback from post-synaptic to
pre-synaptic
45
Q

Release of Neurotransmitter

A

Exocytosis

  • undocked synaptic vesicle
  • docks onto presynaptic membrane with entry of calcium opens fusion pore
  • fusion pore widens membrane and the synaptic vesicle presynaptic membrane
  • molecules of the neurotransmitter begin to leave the terminal button
46
Q

Receptor Activation

A
Released neurotransmitter
molecules produce signals
in postsynaptic neurons by
binding to receptors
• Receptors are specific for a
given neurotransmitter
• Can also be different
receptors for the same
neurotransmitter
47
Q

Receptor Activation- 2 Types of Receptor

A
Ionotropic receptors
• Associated with ligandactivated ion channels
Metabotropic receptors
• Associated with signal proteins
and G proteins
48
Q

Ionotropic Receptors

A
Neurotransmitter binds and
an associated ion channel
opens or closes, causing a
Post-Synaptic Potential (PSP)
• EPSP – inside gets more
positive (usually Na+
flows in)
• IPSP – inside gets more
negative (either K+
flows out or Clflows in)
• Fast acting
49
Q

Metabotropic Receptors

A
G-protein coupled
• Effects slower, longer-lasting,
more diffuse, and more varied
• Neurotransmitter binds.
• G protein subunit breaks away.
• Ion channel opened/closed OR
a 2nd messenger is synthesized.
• 2nd messengers may have a
wide variety of effects.
50
Q

NT Inactivation

A
As long as the
neurotransmitter is in the
synapse, it is active – activity
must somehow be turned off
• Reuptake, Enzymatic
Degradation, and Recycling
• NT can be taken up by presynaptic receptors
• ‘Destroyed’ in the gap, before
they get to the post-synaptic
receptors.
• Taken up by post-synaptic
receptors
51
Q

Seven Steps in Neurotransmitter action

A
  1. neurotransmitter molecules are synthesised from precursors under the influence of enzymes
  2. neurotransmitter molecules are stored in vesicles
  3. neurotransmitter molecules that leak from their vesicles are destroyed by enzymes
  4. Action potentials cause vesicles to fuse with the presynaptic membrane and release their neurotransmitter molecules
  5. released neurotransmitter molecules bind with autoreceptors and inhibit subsequent neurotransmitter release
  6. released neurotransmitter molecules bind to postsynaptic receptors
  7. released neurotransmitter molecules are deactivated by either reuptake or enzymatic degradation
    At terminal button:
    3 classes of “small
    molecule”
    neurotransmitters
    Amino acids
    Monoamines
    Acetylcholine
52
Q

Neuropharmacology

A
A drug may act to alter neurotransmitter activity at any point in its
“life cycle”
• While still in the neuron (pre-synaptically)
• Influence production
• Influence release
• At the synapse ‘ junction’
• Influence destruction
• Influence up-take
• Influence re-uptake
• Agonists – facilitate/enhance
• Antagonists - inhibit
53
Q

Neuropharmacology - Agonists

A

facilitate/enhance
• Coca - catecholamine agonist
• blocks reuptake (DAT) preventing the activity of the neurotransmitter
from being “turned off”
• Benzodiazepines - GABA agonists
• binds to the GABA molecule and increases the binding of GABA
• Physostigmine - ACh agonist
• inhibits acetylcholinesterase, which breaks down ACh

54
Q

Neuropharmacology - Antagonists

A

inhibit
• Atropine – ACh antagonist
• Binds and blocks ACh muscarinic receptors
• Many of these metabotropic receptors are in the brain
• High doses disrupt memory
• Curare – ACh antagonist
• Bind and blocks ACh nicotinic receptors, the ionotropic receptors at
the neuromuscular junction
• Causes paralysis
• Treated with physostigmine

55
Q

Agonistic drug effects

A
-L-dopa increases
synthesis of dopamine
-Black widow spider
venom - increases release of ACh
-Nicotine stimulates ACh receptors
-Amphetamine, cocaine,
methylphenidate - block reuptake of dopamine
56
Q

Antagonistic drug effects

A
-PCPA inhibits the
synthesis of serotonin
-Reserpine prevents
storage of monoamines in
vesicles
-Botulinum toxin blocks
release of ACh
-Apomorphine stimulates
dopamine autoreceptors;
inhibits release of
dopamine
-Curare blocks
postsynaptic ACh
receptors
57
Q

Communication Dysfunction

A
Myasthenia Gravis
• Autoimmune disease (20 per 100,000 US)
• Action potentials in nerves are normal
• Arises from a problem with synapses on
muscles
• Immune system destroys acetylcholine
(ACh) receptors at neuromuscular junction
• Symptoms
• Extreme fatigability
• Fluctuating muscle weakness (proximal>distal)
• Problems chewing (dysphagia) and talking
(dysarthria)
• Respiratory weakness
Treated with acetyl-cholinesterase
(AChE) inhibitors – these increase and
prolong the effects of ACh on the
postsynaptic membrane
• Physostigmine – de-activates
acetylcholinesterase (AChE) = Ach
agonist
• Also treated with immunosuppressive
drugs, or by removal of thymus gland
58
Q

At terminal button:
what are the 3 classes of “small
molecule” neurotransmitters

A

Amino acids
Monoamines
Acetylcholine